PMID: 14486930Mar 1, 1962Paper

Determination of 3-methoxy-4-hydroxymandelic acid in urine

Clinica Chimica Acta; International Journal of Clinical Chemistry
J J PISANOD ABRAHAM

Abstract

No abstract listed.

References

Aug 17, 1957·Lancet·G A MASONN A WYNNE
Aug 1, 1957·Biochimica Et Biophysica Acta·M D ARMSTRONGK N SHAW
Feb 14, 1959·British Medical Journal·H ISAACSW M POLITZER
Jan 1, 1959·The British Journal of Surgery·D M DOUGLAS
Jan 1, 1959·Scandinavian Journal of Clinical and Laboratory Investigation·W VON STUDNITZ, A HANSON
Jun 20, 1959·Nature·J MOULLEC, P LE CHEVREL
Jun 20, 1959·Nature·J D GRAHAM
Mar 1, 1961·American Heart Journal·J R CROUTA SJOERDSMA
Nov 1, 1960·The Journal of Clinical Investigation·R E GREENBERG, L I GARDNER
Mar 1, 1961·The Journal of Clinical Endocrinology and Metabolism·M L VOORHESS, L I GARDNER
Jan 1, 1961·Clinica Chimica Acta; International Journal of Clinical Chemistry·V K WEISEE H LABROSSE
Jan 1, 1960·The Journal of Clinical Investigation·S E GITLOWJ SHA
Jun 1, 1960·The American Journal of Medicine·S E GITLOWE KRUK
May 1, 1960·Clinica Chimica Acta; International Journal of Clinical Chemistry·J J PISANO

Citations

Mar 1, 1968·The Journal of Clinical Pharmacology and the Journal of New Drugs·L E Hollister
Feb 1, 1976·Journal of Clinical Pharmacology·J M FeldmanJ W Plonk
Jan 1, 1967·Psychopharmacologia·S GershonL E Hollister
Jan 1, 1969·Psychopharmacologia·L E HollisterH K Gillespie
Oct 6, 1967·Psychopharmacologia·K D Charalampous, S Brown
Aug 4, 1967·Psychopharmacologia·L E Hollister, F Moore
Sep 23, 1976·European Journal of Applied Physiology and Occupational Physiology·W SkipkaD Böning
Jan 1, 1981·European Journal of Clinical Pharmacology·I M CohenR A Stone
Jan 1, 1982·European Journal of Clinical Pharmacology·E H Sasso, D T O'Connor
Jan 1, 1975·European Journal of Clinical Pharmacology·J H HengstmannH J Dengler
Jan 1, 1978·Journal of Neural Transmission·U K RinneV Sonninen
Jan 1, 1979·Journal of Neural Transmission·R LangW Kaufmann
Jun 15, 1983·Klinische Wochenschrift·H HörtnaglW Druml
Jan 1, 1982·European Journal of Applied Physiology and Occupational Physiology·E Kuhn, V Brodan
Sep 1, 1965·The American Journal of Medicine·C A CHIDSEYA G MORROW
Aug 31, 1983·Clinica Chimica Acta; International Journal of Clinical Chemistry·D RatgeH Wisser
Jan 16, 1984·Clinica Chimica Acta; International Journal of Clinical Chemistry·L Mason, C Weinkove
Dec 31, 1985·Clinica Chimica Acta; International Journal of Clinical Chemistry·K KodamaM Aoyama
Mar 10, 1989·Journal of Immunological Methods·G W MellorJ Landon
Dec 1, 1967·Journal of Psychiatric Research·C R TreadwayP C Whybrow
Jan 1, 1986·Physiology & Behavior·O L TulpO E Michaelis
Jan 1, 1991·Comparative Biochemistry and Physiology. A, Comparative Physiology·O L Tulp
Jan 1, 1980·Progress in Neuro-psychopharmacology·C Q MountjoyM Roth
Jul 24, 2003·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·D T WilliamsM H Wheeler
Nov 26, 1998·Clinical Endocrinology·C Garcia-RudazM Barontini

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Glut1 Deficiency

Glut1 deficiency, an autosomal dominant, genetic metabolic disorder associated with a deficiency of GLUT1, the protein that transports glucose across the blood brain barrier, is characterized by mental and motor developmental delays and infantile seizures. Follow the latest research on Glut1 deficiency with this feed.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

Nodding Syndrome

Nodding Syndrome is a neurological and epileptiform disorder characterized by psychomotor, mental, and growth retardation. Discover the latest research on Nodding Syndrome here.

LRRK2 & Microtubules

Mutations in the LRRK2 gene are risk-factors for developing Parkinson’s disease (PD). LRRK2 mutations in PD have been shown to enhance its association with microtubules. Here is the latest research.

Related Papers

Clinica Chimica Acta; International Journal of Clinical Chemistry
J J PISANO
Clinica Chimica Acta; International Journal of Clinical Chemistry
V K WEISEE H LABROSSE
Clinica Chimica Acta; International Journal of Clinical Chemistry
L J Felice, P T Kissinger
© 2021 Meta ULC. All rights reserved